Cargando…
Development of a SETD2-related immune prognostic signature in clear cell renal cell carcinoma
BACKGROUND: Renal cell carcinoma (RCC) is a malignant tumor of urinary system, and clear cell RCC (ccRCC) is the major pathological subtype. A high-frequency mutation in SETD2 gene is related to the occurrence, development, and poor prognosis of RCC. OBJECTIVE: The research of immune-related genes (...
Autores principales: | Wang, Xingyuan, Xia, Zhinan, Li, Zhiyuan, Zhang, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351884/ https://www.ncbi.nlm.nih.gov/pubmed/35945780 http://dx.doi.org/10.1097/MD.0000000000029561 |
Ejemplares similares
-
A pyroptosis-associated signature plays a role in prognosis prediction in clear cell renal cell carcinoma
por: Li, Zhiyuan, et al.
Publicado: (2022) -
Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma
por: Hua, Shan, et al.
Publicado: (2022) -
The cuproptosis related genes signature predicts the prognosis and correlates with the immune status of clear cell renal cell carcinoma
por: Sun, Peng, et al.
Publicado: (2022) -
Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma
por: Yu, Mengxue, et al.
Publicado: (2023) -
Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma
por: Liu, Yankuo, et al.
Publicado: (2023)